Literature DB >> 12562035

Treatment-related factors and highly active antiretroviral therapy adherence.

Maria Paola Trotta1, Adriana Ammassari, Sara Melzi, Mauro Zaccarelli, Nicoletta Ladisa, Laura Sighinolfi, Maria Stella Mura, Antonella d'Arminio Monforte, Andrea Antinori.   

Abstract

Adherence to highly active antiretroviral therapy (HAART) plays a critical role in the effectiveness of HIV treatment. Nevertheless, the complexity of regimens and frequent side effects make HAART extraordinarily difficult to take, and many HIV-infected persons fail to adhere. The current study offers an overview of the relationship between adherence and antiretroviral treatment-related variables. As for other chronic diseases, medication regimen complexity also has an impact on adherence in the management of HIV infection. In particular, the authors discuss the effect of pill burden, dosing frequency, dietary instructions, number and type of different medications prescribed, short- and long-term side effects, convenience, and ability to incorporate the treatment regimen into a daily routine. Medication side effects are common in HAART-treated persons and are associated with concurrent and future nonadherence. Simplification of regimens, adjustment of the drug schedule to the patient's specific lifestyle, and anticipation and self-management of side effects are treatment-based strategies to optimize HAART adherence and ensure the most effective, convenient, safe, and well-tolerated antiretroviral treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12562035     DOI: 10.1097/00126334-200212153-00008

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  11 in total

Review 1.  Primary drug resistance in South Africa: data from 10 years of surveys.

Authors:  Justen Manasa; David Katzenstein; Sharon Cassol; Marie-Louise Newell; Tulio de Oliveira
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-12       Impact factor: 2.205

Review 2.  The impact of medication regimen factors on adherence to chronic treatment: a review of literature.

Authors:  Karen S Ingersoll; Jessye Cohen
Journal:  J Behav Med       Date:  2008-01-19

3.  Triple Drug Combination of Zidovudine, Efavirenz and Lamivudine Loaded Lactoferrin Nanoparticles: an Effective Nano First-Line Regimen for HIV Therapy.

Authors:  Prashant Kumar; Yeruva Samrajya Lakshmi; Anand K Kondapi
Journal:  Pharm Res       Date:  2016-12-07       Impact factor: 4.200

Review 4.  Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.

Authors:  S Rueda; L Y Park-Wyllie; A M Bayoumi; A M Tynan; T A Antoniou; S B Rourke; R H Glazier
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

5.  Cost effectiveness of lopinavir/ritonavir tablets compared with atazanavir plus ritonavir in antiretroviral-experienced patients in the UK, France, Italy and Spain.

Authors:  Kit N Simpson; Walter J Jones; Rukmini Rajagopalan; Birgitta Dietz
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

Review 6.  Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?

Authors:  Christoph G Lange; Ian J Woolley; Reinhard H Brodt
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Long-term efficacy and safety of once-daily nevirapine in combination with tenofovir and emtricitabine in the treatment of HIV-infected patients: a 72-week prospective multicenter study (TENOR-trial).

Authors:  T Weberschock; P Gholam; E Hueter; K Flux; M Hartmann
Journal:  Eur J Med Res       Date:  2009       Impact factor: 2.175

8.  Lower Cumulative Antiretroviral Exposure in People Living With HIV and Diabetes Mellitus.

Authors:  Sarah C Mann; Mary Morrow; Ryan P Coyle; Stacey S Coleman; Austin Saderup; Jia-Hua Zheng; Lucas Ellison; Lane R Bushman; Jennifer J Kiser; Samantha MaWhinney; Peter L Anderson; Jose R Castillo-Mancilla
Journal:  J Acquir Immune Defic Syndr       Date:  2020-12-01       Impact factor: 3.771

Review 9.  Targeting Medication Non-Adherence Behavior in Selected Autoimmune Diseases: A Systematic Approach to Digital Health Program Development.

Authors:  Trevor van Mierlo; Rachel Fournier; Michael Ingham
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

10.  Efavirenz-induced gynecomastia in a prepubertal girl with human immunodeficiency virus infection: a case report.

Authors:  Mette S van Ramshorst; Magdeline Kekana; Helen E Struthers; James A McIntyre; Remco P H Peters
Journal:  BMC Pediatr       Date:  2013-08-13       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.